Literature DB >> 332216

Factors influencing antipyrine elimination.

I H Stevenson.   

Abstract

Mesh：

Substances：

Year:  1977        PMID： 332216      PMCID： PMC1429089          DOI： 10.1111/j.1365-2125.1977.tb00710.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  21 in total

1.  The fate of antipyrine in man.

Authors:  B B BRODIE; J AXELROD
Journal:  J Pharmacol Exp Ther       Date:  1950-01       Impact factor: 4.030

2.  Drug-metabolizing capacity in states of drug dependence and withdrawal.

Authors:  B Ballinger; M Browning; K O'Malley; I H Stevenson
Journal:  Br J Pharmacol       Date:  1972-08       Impact factor: 8.739

3.  Metabolism of drugs. LIX. A new metabolite of antipyrine.

Authors:  H Yoshimura; H Shimeno; H Tsukamoto
Journal:  Biochem Pharmacol       Date:  1968-08       Impact factor: 5.858

4.  Iron deficiency anaemia and drug metabolism.

Authors:  K O'Malley; I H Stevenson
Journal:  J Pharm Pharmacol       Date:  1973-04       Impact factor: 3.765

5.  Norphenazone, a new metabolite of phenazone in human urine.

Authors:  J D Baty; D A Evans
Journal:  J Pharm Pharmacol       Date:  1973-01       Impact factor: 3.765

6.  Prediction of drug oxidation rates in man: lack of correlation with serum gamma-glutamyl transpeptidase and urinary excretion of D-glucaric acid and 6 beta-hydroxycortisol.

Authors:  S E Smith; M D Rawlins
Journal:  Eur J Clin Pharmacol       Date:  1974       Impact factor: 2.953

7.  Drug metabolizing ability in operating theatre personnel.

Authors:  M Wood; K O'Malley; I H Stevenson
Journal:  Br J Anaesth       Date:  1974-10       Impact factor: 9.166

Review 8.  Pharmacokinetics in the elderly.

Authors:  J Crooks; K O'Malley; I H Stevenson
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

9.  Increased clearance of antipyrine and d-propranolol after phenobarbital treatment in the monkey. Relative contributions of enzyme induction and increased hepatic blood flow.

Authors:  R A Branch; D G Shand; G R Wilkinson; A S Nies
Journal:  J Clin Invest       Date:  1974-04       Impact factor: 14.808

10.  Abnormal drug metabolism after barbiturate and paracetamol overdose.

Authors:  J A Forrest; P Roscoe; L F Prescott; I H Stevenson
Journal:  Br Med J       Date:  1974-11-30
View more
  42 in total

1.  Drug metabolism in malnourished children: a study with antipyrine.

Authors:  M Homeida; Z A Karrar; C J Roberts
Journal:  Arch Dis Child       Date:  1979-04       Impact factor: 3.791

2.  Effect of erythrocytes on the hepatic distribution kinetics of antipyrine.

Authors:  Selma Sahin; Malcolm Rowland
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2004 Jan-Mar       Impact factor: 2.441

3.  Disposition of antipyrine in patients with extensive metastatic liver disease.

Authors:  G M Robertz-Vaupel; K D Lindecken; T Edeki; C Funke; S Belwon; H J Dengler
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

4.  Nutrition and drug disposition.

Authors:  S Mehta
Journal:  Indian J Pediatr       Date:  1986 Mar-Apr       Impact factor: 1.967

5.  Induction of microsomal drug metabolism in man and in the rat by exposure to petroleum.

Authors:  A W Harman; D B Frewin; B G Priestly
Journal:  Br J Ind Med       Date:  1981-02

6.  The features of hepatic enzyme induction with glutethimide in man.

Authors:  L Jackson; M Homeida; C J Roberts
Journal:  Br J Clin Pharmacol       Date:  1978-12       Impact factor: 4.335

7.  Antipyrine disposition and liver size in the elderly.

Authors:  C G Swift; M Homeida; M Halliwell; C J Roberts
Journal:  Eur J Clin Pharmacol       Date:  1978-11-16       Impact factor: 2.953

8.  The disposition of antipyrine and its metabolites in young and elderly healthy volunteers.

Authors:  J Posner; M Danhof; M W Teunissen; D D Breimer; P D Whiteman
Journal:  Br J Clin Pharmacol       Date:  1987-07       Impact factor: 4.335

9.  Effects of cirrhosis and ageing on the elimination and bioavailability of ranitidine.

Authors:  C J Young; T K Daneshmend; C J Roberts
Journal:  Gut       Date:  1982-10       Impact factor: 23.059

10.  Enhanced drug metabolism after sulfinpyrazone treatment in patients aged 50 to 60 years.

Authors:  E Walter; C Staiger; J de Vries; E Weber; W Bitzer; M Degott; K Jüngling
Journal:  Klin Wochenschr       Date:  1982-11-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.